| # | Country | Total Patents | |
|---|---|---|---|
| #1 | United States | 7 | |
| #2 | Canada | 2 | |
| #3 | Australia | 1 | |
| #4 | EPO (European Patent Office) | 1 | |
| #5 | WIPO (World Intellectual Property Organization) | 1 |
| # | Industry | |
|---|---|---|
| #1 | Pharmaceuticals | |
| #2 | Biotechnology | |
| #3 | Measurement | |
| #4 | Machines |
| # | Technology | |
|---|---|---|
| #1 | Therapeutic chemical compounds | |
| #2 | Medical preparations | |
| #3 | Analysing materials | |
| #4 | Peptides | |
| #5 | Measuring microorganism processes | |
| #6 | Unspecified technologies |
| # | Name | Total Patents |
|---|---|---|
| #1 | Harris Adrian L | 12 |
| #2 | Liu Stanley K | 4 |
| #3 | Muschel Ruth | 4 |
| #4 | Ratcliffe Peter J | 4 |
| #5 | Vordermark Dirk | 2 |
| #6 | Kangas Lauri V M | 2 |
| #7 | Degregorio Michael W | 2 |
| #8 | Cho Sanghee | 1 |
| #9 | Ginty Fiona | 1 |
| #10 | Gokmen-Polar Yesmin | 1 |
| Publication | Filing date | Title |
|---|---|---|
| US2020174000A1 | Materials and methods for detecting and/or treating ductal carcinoma in situ and related symptoms | |
| CA2838973A1 | Methods of enhancing the response to radiation in tumor therapy using anti-dll4 antibodies | |
| US2009239247A1 | MN and Hypoxia | |
| US2009047215A1 | MN/CA IX and breast cancer therapy | |
| US2008206765A1 | MN gene and protein | |
| US2006084123A1 | MN and hypoxia | |
| US4990538A | Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs |